The wearable cardioverter-defibrillator: current technology and evolving indications

Reek S., Burri H., Roberts P. R., Perings C., Epstein A. E., Klein H. U.

EUROPACE, vol.19, no.3, pp.335-345, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 19 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.1093/europace/euw180
  • Journal Name: EUROPACE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.335-345
  • Keywords: Wearable cardioverter-defibrillator, Sudden cardiac death, Ventricular arrhythmias, External defibrillation, Life vest, SUDDEN CARDIAC DEATH, ACUTELY TERMINATING EPISODES, LEFT-VENTRICULAR DYSFUNCTION, ASSOCIATION TASK-FORCE, MYOCARDIAL-INFARCTION, HIGH-RISK, PERIPARTUM CARDIOMYOPATHY, PRACTICE GUIDELINES, CLINICAL-EFFICACY, AMERICAN-COLLEGE
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.